AstraZeneca Expands Rare Disease Pipeline with Amolyt Pharma Acquisition
AstraZeneca has announced it is set to acquire Amolyt Pharma, a French clinical-stage biotechnology company focused on developing novel treatments
Read moreAstraZeneca has announced it is set to acquire Amolyt Pharma, a French clinical-stage biotechnology company focused on developing novel treatments
Read moreDetermination of the Plasma Protein Binding of Liraglutide Using the EScalate* Equilibrium Shift Assay A Sovicell White Paper Evaluation of
Read moreOrano Med, a clinical-stage biotechnology company that develops the next generation of targeted therapies against cancer using the unique properties
Read morePeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kanagawa, Japan, led by President and CEO Patrick C. Reid, has
Read moreBiosynth extends its array of GMP-compliant peptide synthesis services, tailored to cater to both peptide NCEs and commercial peptides. Harmonizing
Read moreStressMarq provides a cutting-edge selection of Amyloid Beta Pre-formed Fibrils (PFFs), Oligomers, and Monomers specifically designed to facilitate advanced neurodegenerative
Read moreBiosynth specialises in Chemical Synthesis and Contract Development and Manufacturing Organization (CDMO) services, providing a comprehensive range of bulk and
Read moreBiosynth provides an exceptional range of chemicals, peptides and biochemicals, offering scientists and researchers worldwide unparalleled convenience, choice, and dependability.
Read moreCellendes specialises in synthetic peptides for cell-matrix adhesion. Cellular adhesion to the hydrogel matrix, which is essential for cellular growth,
Read moreA pan-tumor IHC screen identified high fibroblast activating protein (FAP) expression in multiple tumor types that correlated with in vitro
Read more